Erythromycin Ointment
Product Images NDC 48102-057

Product Visual Gallery

This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Erythromycin (NDC 48102-057). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Fera Pharmaceuticals, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Figure (Ery06 0000 01)

Chemical structure diagram showing the molecular formula and molecular weight of erythromycin ophthalmic ointment, 5 mg/g. The diagram depicts the detailed molecular bonds and atoms composing erythromycin.*

FDA Label Image

Figure (Ery06 0000 02)

Packaging label for Erythromycin Ophthalmic Ointment USP, 5 mg/g, in unit dose tubes of 1 g, with a total package size of 50 tubes. The label includes bilingual text in English and French, and indicates the product is sterile. The labeler is Steri-med Pharma, located in Upton, Quebec, Canada. Instructions and contact information for questions or concerns are also present.*

FDA Label Image

Figure (Ery06 0000 03)

Carton label for Erythromycin Ophthalmic Ointment USP 5 mg/g by Sterigen. The label is bilingual (English and French) and includes indications for external ocular infections, dosage instructions, and storage conditions. The label specifies a package of 50 single-dose 1g tubes. Manufactured by Sterigen, located in Canada.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.